ZYME Zymeworks Inc. - Common Stock
$25,55
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$13–$30
74% of range
Analystenbewertung
BUY
18 analysts
Kursziel
$40
+58% upside
P/E (TTM)
-23.7
ROE
-26.9%
Nettogewinnmarge
-76.6%
Über Zymeworks Inc. - Common Stock Unternehmensübersicht von Wikipedia
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
Mehr lesen
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver,
British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
In May 2019, Zymeworks announced that GSK has expanded its 2016 licensing and collaboration agreement for the research, development and commercialization of bispecific antibodies across multiple disease areas. The extended agreement has meant that GSK can have access to Zymeworks' heavy-light chain pairing technology, which enables the development of bispecific and multifunctional therapeutics.
In September 2019, Zymeworks announced that, following their clinical trials, it has been confirmed that their ZW25 monotherapy can provide durable disease control in patients with a variety of HER2-expressing solid tumors that have progressed following standard of care treatments.
In May 2022, Zymeworks rejected an unsolicited takeover proposal from a Dubai hedge fund, All Blue Falcons FZE, an arm of All Blue Capital.
Azymetric
This is an IgG1-based heterodimeric antibody scaffold that consists of two different heavy chains engineered to exclusively assemble into a single molecule, allowing bi-specific binding to two different antigens or drug targets. The Azymetric scaffold is engineered by making amino acid changes in the CH3 region of the constant Fc domain of the IgG1. This scaffold can also be engineered with tailored effector function and optimized serum half-life.
Awards and recognition
Deal of the Year, Lifesciences BC Awards, 2018
Life Sciences Company of the Year, Lifesciences BC Awards, 2016
Emerging company of the year – Health, BIOTECanada Gold Leaf Awards, 2015
12th Place, BC's Leading Innovators, 2011
Life Science Emerging Rocket, 2009, 2010, 2011
Early stage Company of the year – Industrial & Agriculture, BIOTECanada Gold Leaf Awards, 2009
== References ==
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
ZYME Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$25.55
Marktkapitalisierung
$1.91B
P/E (TTM)
-23.7
EPS (TTM)
$-1.08
Umsatz (TTM)
$106M
Dividendenrendite
—
ROE
-26.9%
Verschuldungsgrad
—
52W-Spanne
$13 – $30
ZYME Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$106M
2020-12-31
→
2025-12-31
EPS
$-1.08
2020-12-31
→
2025-12-31
Freier Cashflow
$-35M
2023-12-31
→
2025-12-31
Margen
-76.6%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ZYME
Peer-Median
P/E (TTM)
-23.7
—
P/S (TTM) (K/V (TTM))
18.0
418.4
P/B (K/B)
7.1
2.3
Price / FCF (Kurs / FCF)
-55.2
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ZYME
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-87.3%
—
Net Profit Margin (Nettogewinnmarge)
-76.6%
-549.8%
ROA
-20.0%
-41.8%
ROE
-26.9%
-54.1%
ROIC
-35.1%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ZYME
Peer-Median
Current Ratio (Liquiditätsgrad)
5.9
12.6
Quick Ratio
1.1
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ZYME
Peer-Median
Revenue YoY (Umsatz YoY)
38.9%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
-36.4%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
22.2%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ZYME
Peer-Median
ZYME Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
18 Analysten
- Starker Kauf 6 33,3%
- Kauf 11 61,1%
- Halten 1 5,6%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
12 Analysten · 2026-08-16
Median
$38.50
← Unter allen Zielen
$25.55
Tief
$31.00
Hoch
$58.00
Median-Ziel
$38.50
+50,7%
Mittelwert-Ziel
$40.33
+57,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.62 | $-0.50 | -0.12% |
| 31. März 2026 | $-0.59 | $-0.20 | -0.39% |
| 31. Dezember 2025 | $-0.55 | $-0.42 | -0.13% |
| 30. September 2025 | $-0.26 | $-0.33 | 0.07% |
| 30. Juni 2025 | $0.03 | $-0.50 | 0.53% |
| 31. März 2025 | $-0.30 | $-0.42 | 0.12% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| AUPH | $2.11B | 7.7 | 20.4% | 101.5% | 62.7% | — |
| ABUS | $926M | -28.3 | 128.2% | -237.9% | -42.0% | — |
| ACOG | $141M | -5.5 | — | -202.2% | -43.8% | — |
| PMN | $15M | -0.3 | — | — | 4840.3% | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $106M | $76M | $76M | $412M | $27M | |
| R&D Expense | · | · | $144M | $209M | $200M | |
| SG&A Expense | $62M | $62M | $70M | $73M | $43M | |
| Operating Expenses | $199M | $213M | $214M | $282M | $242M | |
| Operating Income | $-93M | $-137M | $-138M | $131M | $-216M | |
| Other Non-op | $51.0K | $-218.0K | $291.0K | $-42.0K | $118.0K | |
| Pretax Income | $-80M | $-117M | $-119M | $135M | $-212M | |
| Income Tax | $1M | $6M | $-568.0K | $11M | $-516.0K | |
| Net Income | $-81M | $-123M | $-119M | $124M | $-212M | |
| EPS (Basic) | $-1.08 | $-1.62 | $-1.72 | $1.91 | $-4.11 | |
| EPS (Diluted) | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 | |
| Shares (Basic) | 75,404,897 | 75,846,681 | 68,863,010 | 65,194,775 | 51,553,869 | |
| Shares (Diluted) | 75,413,396 | 75,878,738 | 68,863,010 | 65,249,184 | 52,131,596 | |
| EBITDA | $-93M | $-137M | $-138M | · | · |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $66M | $158M | $401M | $202M | |
| Short-term Investments | · | · | $217M | $91M | $51M | |
| Receivables | $5M | $56M | $19M | $33M | $16M | |
| Prepaid Expense | $15M | $19M | $19M | $19M | $20M | |
| Current Assets | $249M | $300M | $413M | $545M | $288M | |
| PP&E (Net) | $16M | $18M | $20M | $25M | $23M | |
| PP&E (Gross) | $36M | $35M | $41M | $38M | $37M | |
| Accum. Depreciation | $21M | $18M | $21M | $13M | $14M | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | |
| Intangibles | $1M | $5M | $8M | $9M | $4M | |
| Total Assets | $347M | $463M | $581M | $649M | $389M | |
| Accounts Payable | $36M | $60M | $46M | $87M | $63M | |
| Current Liabilities | $42M | $88M | $56M | $96M | $72M | |
| Capital Leases | $15M | $16M | $22M | $25M | $31M | |
| Deferred Tax | $6M | $5M | $3M | $2M | $2M | |
| Other Non-current Liabilities | $278.0K | $923.0K | $2M | $3M | $3M | |
| Total Liabilities | $78M | $124M | $116M | $156M | $140M | |
| Common Stock | $1.11B | $1.02B | $997M | $886M | $741M | |
| Retained Earnings | $-953M | $-830M | $-677M | $-559M | $-683M | |
| AOCI | $-6M | $-7M | $-7M | $-7M | $-7M | |
| Stockholders' Equity | $269M | $339M | $465M | $493M | $249M | |
| Liabilities + Equity | $347M | $463M | $581M | $649M | $389M | |
| Shares Outstanding | 74,638,413 | 68,964,319 | 70,115,997 | 63,059,501 | 46,633,935 |
Cashflow 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $28M | $18M | $8M | $4M | $11M | |
| Deferred Tax | $945.0K | $691.0K | $-757.0K | $2M | $-953.0K | |
| Amort. of Intangibles | $4M | $4M | $3M | $1M | $3M | |
| Restructuring | · | · | $0 | · | · | |
| Operating Cash Flow | $-33M | $-110M | $-118M | $144M | $-192M | |
| CapEx | $2M | $2M | $2M | $8M | $12M | |
| Investing Cash Flow | $27M | $39M | $-207M | $-54M | $145M | |
| Stock Issued | $0 | $0 | $26M | $108M | $0 | |
| Stock Repurchased | $42M | $30M | $0 | $0 | · | |
| Net Stock Activity | $-42M | $-30M | $26M | · | · | |
| Financing Cash Flow | $-19M | $-20M | $82M | $109M | $8M | |
| Net Change in Cash | $-25M | $-91M | $-243M | $199M | $-40M | |
| Taxes Paid | $1M | $3M | $165.0K | $10M | · | |
| Free Cash Flow | $-35M | $-112M | $-121M | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -87.3% | -179.7% | -181.6% | · | · | |
| Net Margin | -76.6% | -160.8% | -156.1% | · | · | |
| Pretax Margin | -75.3% | -152.8% | -156.9% | · | · | |
| EBITDA Margin | -87.3% | -179.7% | -181.6% | · | · | |
| ROA | -20.0% | -23.5% | -19.3% | · | · | |
| ROE | -26.9% | -34.8% | -26.7% | · | · | |
| ROIC | -35.1% | -42.6% | -29.6% | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 3.4 | 7.4 | · | · | |
| Quick Ratio | 1.1 | 1.4 | 7.1 | · | · |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 3.5 | 2.0 | 2.9 | · | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 38.9% | 0.38% | -81.6% | 1446.0% | -31.5% | |
| Revenue CAGR 3Y | -36.4% | 41.9% | 25.0% | · | · | |
| Revenue CAGR 5Y | 22.2% | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $106M | $76M | $76M | $412M | · | |
| Net Income TTM | $-81M | $-123M | $-119M | $124M | · | |
| Market Cap | $1.97B | $1.01B | $729M | · | · | |
| P/E | -24.4 | -9.0 | -6.0 | 4.1 | · | |
| P/S | 18.5 | 13.2 | 9.6 | · | · | |
| P/B | 7.3 | 3.0 | 1.6 | · | · | |
| P / Tangible Book | 7.7 | 3.1 | 1.6 | 1.0 | · | |
| P / Cash Flow | -59.5 | -9.2 | -6.2 | · | · | |
| P / FCF | -56.9 | -9.0 | -6.0 | · | · | |
| Earnings Yield | -4.1% | -11.1% | -16.6% | 24.2% | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $2M | $3M | $28M | $49M | $27M | $31M | $16M | $19M | $10M | $17M | $17M | $7M | $36M | $402M | $3M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $32M | · | $33M | $39M | $46M | · | $37M | |
| SG&A Expense | $19M | $15M | $15M | $14M | $15M | $17M | $16M | $14M | $16M | $16M | $15M | $17M | $22M | $17M | $30M | $16M | |
| Operating Expenses | $47M | $50M | $47M | $50M | $49M | $53M | $53M | $50M | $62M | $48M | $40M | $50M | $61M | $63M | $83M | $53M | |
| Operating Income | $-42M | $-47M | $-44M | $-22M | $-674.0K | $-26M | $-22M | $-34M | $-43M | $-38M | $-23M | $-33M | $-54M | $-27M | $319M | $-50M | |
| Other Non-op | $196.0K | $120.0K | $-18.0K | $26.0K | $-621.0K | $49.0K | $-253.0K | $-37.0K | $53.0K | $19.0K | $-278.0K | $370.0K | $230.0K | $-31.0K | $-27.0K | $-98.0K | |
| Pretax Income | $-45M | $-46M | $-41M | $-18M | $2M | $-22M | $-18M | $-30M | $-38M | $-32M | $-19M | $-28M | $-49M | $-23M | $320M | $-48M | |
| Income Tax | $-273.0K | $-2M | $-270.0K | $1M | $-186.0K | $496.0K | $6M | $226.0K | $68.0K | $75.0K | $-5M | $1M | $2M | $1M | $11M | $-29.0K | |
| Net Income | $-45M | $-44M | $-41M | $-20M | $2M | $-23M | $-24M | $-30M | $-38M | $-32M | $-14M | $-29M | $-51M | $-24M | $309M | $-48M | |
| EPS (Basic) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.19 | $-0.41 | $-0.76 | $-0.36 | $4.78 | $-0.72 | |
| EPS (Diluted) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.18 | $-0.41 | $-0.76 | $-0.37 | $4.78 | $-0.72 | |
| Shares (Basic) | 72,993,313 | 74,668,790 | -150,871,069 | 75,767,778 | 75,337,168 | 75,171,020 | -152,889,276 | 76,128,531 | 76,392,593 | 76,214,833 | -135,733,099 | 70,575,773 | 67,281,028 | 66,739,308 | -129,002,888 | 66,477,016 | |
| Shares (Diluted) | 72,993,313 | 74,694,762 | -152,966,654 | 75,775,214 | 77,378,449 | 75,226,387 | -152,922,738 | 76,157,101 | 76,396,217 | 76,248,158 | -135,739,304 | 70,575,773 | 67,284,511 | 66,742,030 | -128,961,927 | 66,478,157 | |
| EBITDA | $-42M | $-47M | · | $-22M | $-674.0K | $-26M | · | $-34M | $-43M | $-38M | · | $-33M | $-54M | $-27M | · | $-50M |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $179M | $244M | $41M | $65M | $98M | $76M | $66M | $122M | $71M | $115M | · | $94M | $142M | $182M | · | $96M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $201M | $198M | $159M | · | $70M | |
| Receivables | $6M | $5M | $5M | $29M | $3M | $25M | $56M | $24M | $32M | $31M | · | $67M | $49M | $67M | · | $7M | |
| Prepaid Expense | $22M | $16M | $15M | $10M | $12M | $17M | $19M | $23M | $21M | $18M | · | $12M | $31M | $19M | · | $18M | |
| Current Assets | $298M | $386M | $249M | $292M | $296M | $306M | $300M | $344M | $383M | $394M | · | $375M | $420M | $426M | · | $191M | |
| PP&E (Net) | $14M | $15M | $16M | $16M | $16M | $17M | $18M | $18M | $18M | $19M | · | $21M | $22M | $24M | · | $26M | |
| PP&E (Gross) | · | · | $36M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $21M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Intangibles | $998.0K | $1M | $1M | $1M | $2M | $3M | $5M | $6M | $7M | $7M | · | $8M | $7M | $8M | · | $9M | |
| Total Assets | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Accounts Payable | $27M | $30M | $36M | $34M | $31M | $38M | $60M | $52M | $44M | $47M | · | $68M | $70M | $59M | · | $52M | |
| Current Liabilities | $47M | $36M | $42M | $42M | $39M | $65M | $88M | $84M | $55M | $57M | · | $73M | $94M | $67M | · | $58M | |
| Capital Leases | $13M | $14M | $15M | $16M | $15M | $15M | $16M | $17M | $17M | $21M | · | $22M | $23M | $24M | · | $25M | |
| Deferred Tax | $4M | $4M | $6M | $5M | $5M | $5M | $5M | $3M | $3M | $3M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $278.0K | $278.0K | $278.0K | $278.0K | $828.0K | $856.0K | $923.0K | $929.0K | $1M | $2M | · | $2M | $4M | $4M | · | $3M | |
| Total Liabilities | $317M | $315M | $78M | $77M | $74M | $101M | $124M | $120M | $109M | $116M | · | $132M | $153M | $127M | · | $121M | |
| Common Stock | $1.13B | $1.13B | $1.11B | $1.09B | $1.07B | $1.02B | $1.02B | $1.01B | $1.01B | $1.00B | · | $932M | $929M | $900M | · | $885M | |
| Retained Earnings | $-1.17B | $-1.07B | $-953M | $-886M | $-851M | $-853M | $-830M | $-798M | $-747M | $-709M | · | $-663M | $-634M | $-583M | · | $-868M | |
| AOCI | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-6M | $-8M | $-8M | · | $-8M | $-8M | $-6M | · | $-7M | |
| Stockholders' Equity | $80M | $164M | $269M | $320M | $335M | $325M | $339M | $367M | $406M | $438M | $465M | $424M | $449M | $474M | $493M | $180M | |
| Liabilities + Equity | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Shares Outstanding | 71,412,072 | 73,102,689 | 74,638,413 | 75,139,281 | 74,846,147 | 69,584,811 | 68,964,319 | 69,584,882 | 70,831,545 | 70,677,106 | · | 67,922,559 | 67,687,384 | 64,083,770 | · | 61,694,387 |
Cashflow 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $7M | $9M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $367.0K | $2M | $4M | $5M | |
| Amort. of Intangibles | $176.0K | $176.0K | $185.0K | $648.0K | $2M | $2M | $2M | $980.0K | $812.0K | $702.0K | $673.0K | $672.0K | $678.0K | $679.0K | $529.0K | $166.0K | |
| Operating Cash Flow | $-32M | $-46M | $-10M | $-31M | $12M | $-3M | $-42M | $-6M | $-25M | $-38M | $14M | $-43M | $-6M | $-83M | $327M | $-73M | |
| CapEx | $0 | $216.0K | $581.0K | $410.0K | $514.0K | $16.0K | $314.0K | $899.0K | $593.0K | $185.0K | $356.0K | $930.0K | $802.0K | $386.0K | $348.0K | $981.0K | |
| Investing Cash Flow | $17M | $70M | $5M | $368.0K | $9M | $12M | $-6M | $72M | $-20M | $-7M | $-1M | $-7M | $-61M | $-138M | $-22M | $-30M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | $26M | $0 | $0 | $0 | |
| Stock Repurchased | $52M | $76M | $25M | $16M | $0 | $0 | $9M | · | · | · | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $-76M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-50M | $179M | $-19M | $-2M | $1M | $1M | $-9M | $-15M | $1M | $2M | $51M | $2M | $28M | $2M | $-377.0K | $628.0K | |
| Net Change in Cash | $-65M | $203M | $-24M | $-33M | $22M | $10M | $-56M | $51M | $-44M | $-43M | $63M | $-48M | $-39M | $-219M | $305M | $-103M | |
| Taxes Paid | $863.0K | $245.0K | $107.0K | $660.0K | $196.0K | $387.0K | $3M | $106.0K | $106.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-46M | · | · | · | $-3M | · | · | · | $-38M | · | · | · | $-84M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| Net Margin | -980.8% | -1834.0% | · | -71.0% | 4.8% | -83.5% | · | -186.6% | -195.8% | -315.6% | · | -173.8% | -730.5% | -68.5% | · | -1818.6% | |
| Pretax Margin | -986.8% | -1925.0% | · | -66.1% | 4.4% | -81.7% | · | -185.2% | -195.5% | -314.8% | · | -167.1% | -706.9% | -64.5% | · | -1819.7% | |
| EBITDA Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| ROA | -11.2% | -9.8% | · | -4.4% | 0.50% | -4.6% | · | -5.7% | -6.7% | -5.5% | · | -6.7% | -17.0% | -8.1% | · | -31.9% | |
| ROE | -21.7% | -18.1% | · | -5.7% | 0.63% | -5.9% | · | -7.5% | -8.8% | -6.9% | · | -9.5% | -22.8% | -10.3% | · | -53.2% | |
| ROIC | -52.2% | -27.4% | · | -7.4% | -0.22% | -8.1% | · | -9.4% | -10.6% | -8.6% | · | -8.2% | -12.5% | -6.1% | · | -28.0% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.3 | 10.8 | · | 6.9 | 7.7 | 4.7 | · | 4.1 | 7.0 | 6.9 | · | 5.1 | 4.5 | 6.3 | · | 3.3 | |
| Quick Ratio | 3.9 | 7.0 | · | 2.2 | 2.6 | 1.5 | · | 1.7 | 1.9 | 2.6 | · | 5.0 | 4.2 | 6.1 | · | 3.0 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.2 | · | 1.0 | 2.8 | 1.0 | · | 0.4 | 0.5 | 0.2 | · | 0.4 | 0.3 | 1.1 | · | 0.8 |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $83M | $106M | · | $119M | $111M | $72M | · | $62M | $53M | $69M | · | $62M | $51M | $46M | · | $14M | |
| Net Income TTM | $-106M | $-84M | · | $-70M | $-88M | $-122M | · | $-128M | $-149M | $-136M | · | $-152M | $-188M | $-209M | · | $-246M | |
| Market Cap | $1.87B | $1.83B | · | $1.28B | $939M | $829M | · | $873M | $603M | $744M | · | $431M | $585M | $579M | · | $379M | |
| P/E | -18.2 | -22.4 | · | -18.6 | -10.9 | -7.4 | · | -7.3 | -4.1 | -5.4 | · | -2.8 | -3.1 | -2.8 | · | -1.5 | |
| P/S | 22.4 | 17.3 | · | 10.7 | 8.5 | 11.4 | · | 14.1 | 11.4 | 10.8 | · | 7.0 | 11.5 | 12.7 | · | 26.4 | |
| P/B | 23.2 | 11.2 | · | 4.0 | 2.8 | 2.6 | · | 2.4 | 1.5 | 1.7 | · | 1.0 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 27.7 | 12.2 | · | 4.2 | 2.9 | 2.7 | · | 2.5 | 1.6 | 1.8 | · | 1.1 | 1.4 | 1.3 | · | 2.4 | |
| P / Cash Flow | · | -40.0 | · | · | · | -243.3 | · | · | · | -19.7 | · | · | · | -7.0 | · | · | |
| P / FCF | · | -39.9 | · | · | · | -242.1 | · | · | · | -19.6 | · | · | · | -6.9 | · | · | |
| Earnings Yield | -5.5% | -4.5% | · | -5.4% | -9.2% | -13.4% | · | -13.6% | -24.4% | -18.6% | · | -35.6% | -32.6% | -35.9% | · | -67.2% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $106M | $76M | $76M | $412M | $27M |
| Betriebsgewinnmarge % | -87.3% | -179.7% | -181.6% | — | — |
| Nettoergebnis | $-81M | $-123M | $-119M | $124M | $-212M |
| Verwässerte EPS | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 5.9 | 3.4 | 7.4 | — | — |
| Quick Ratio | 1.1 | 1.4 | 7.1 | — | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-35M | $-112M | $-121M | — | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 218 Einreicher · $1.5B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 30 (-4 vs. Vorquartal) | 29 (-2 vs. Vorquartal) | 56 (-17 vs. Vorquartal) | 68 (+9 vs. Vorquartal) | +2.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $600.445.942 | 22.970.388 | 39,27% | Aktien |
| Rubric Capital Management LP | $182.980.000 | 7.000.000 | 11,97% | Aktien |
| PERCEPTIVE ADVISORS LLC | $109.342.391 | 4.182.953 | 7,15% | Aktien |
| BVF INC/IL | $95.388.572 | 3.649.142 | 6,24% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $40.752.208 | 1.558.998 | 2,67% | Aktien |
| Assenagon Asset Management S.A. | $32.727.986 | 1.252.027 | 2,14% | Aktien |
| Nextech Invest Ltd. | $29.118.548 | 1.113.946 | 1,90% | Aktien |
| STATE STREET CORP | $28.445.966 | 1.088.216 | 1,86% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $24.486.776 | 936.755 | 1,60% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23.259.000 | 889.802 | 1,52% | Aktien |
| CITADEL ADVISORS LLC | $21.330.894 | 816.025 | 1,40% | Aktien |
| FMR LLC | $18.355.822 | 702.212 | 1,20% | Aktien |
| Prosight Management, LP | $17.629.705 | 674.434 | 1,15% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $16.322.460 | 624.447 | 1,07% | Aktien |
| Nextech Invest Ltd. | $16.308.169 | 1.113.946 | 1,07% | Aktien |
| Qube Research & Technologies Ltd | $15.516.443 | 593.590 | 1,01% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.332.236 | 510.032 | 0,87% | Aktien |
| Redmile Group, LLC | $12.851.836 | 491.654 | 0,84% | Aktien |
| Capricorn Fund Managers Ltd | $12.717.868 | 486.529 | 0,83% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10.939.512 | 418.497 | 0,72% | Aktien |
| Hillsdale Investment Management Inc. | $10.009.581 | 382.922 | 0,65% | Aktien |
| GOLDMAN SACHS GROUP INC | $9.345.338 | 357.511 | 0,61% | Aktien |
| FIRST TRUST ADVISORS LP | $8.897.088 | 340.363 | 0,58% | Aktien |
| Granahan Investment Management, LLC | $8.787.144 | 336.157 | 0,57% | Aktien |
| Pictet Asset Management Holding SA | $7.446.189 | 308.187 | 0,49% | Aktien |
| PICTON MAHONEY ASSET MANAGEMENT | $7.092.908 | 271.343 | 0,46% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5.849.243 | 223.766 | 0,38% | Aktien |
| SummitTX Capital, L.P. | $5.510.364 | 210.802 | 0,36% | Aktien |
| Man Group plc | $5.509.763 | 210.779 | 0,36% | Aktien |
| BANK OF AMERICA CORP /DE/ | $5.182.437 | 198.257 | 0,34% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $4.066.835 | 155.579 | 0,27% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.984.154 | 152.416 | 0,26% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3.960.132 | 151.497 | 0,26% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $3.800.390 | 145.386 | 0,25% | Aktien |
| D. E. Shaw & Co., Inc. | $3.785.255 | 144.807 | 0,25% | Aktien |
| DIADEMA PARTNERS LP | $3.715.330 | 142.132 | 0,24% | Aktien |
| BlackRock, Inc. | $3.614.744 | 138.284 | 0,24% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.408.656 | 130.400 | 0,22% | Kaufoption |
| CITIGROUP INC | $3.364.872 | 128.725 | 0,22% | Aktien |
| XTX Topco Ltd | $3.290.425 | 125.877 | 0,22% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $3.100.282 | 118.603 | 0,20% | Aktien |
| PLATINUM INVESTMENT MANAGEMENT LTD | $2.749.510 | 105.184 | 0,18% | Aktien |
| AXA Investment Managers S.A. | $2.705.745 | 158.416 | 0,18% | Aktien |
| Manatuck Hill Partners, LLC | $2.614.000 | 100.000 | 0,17% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.451.932 | 93.800 | 0,16% | Verkaufsoption |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $2.321.232 | 88.800 | 0,15% | Aktien |
| MACKENZIE FINANCIAL CORP | $2.293.654 | 87.745 | 0,15% | Aktien |
| VANGUARD GROUP INC | $2.251.979 | 85.529 | 0,15% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $2.181.514 | 83.455 | 0,14% | Aktien |
| LMR Partners LLP | $2.156.550 | 82.500 | 0,14% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $2.127.587 | 81.392 | 0,14% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.094.337 | 80.120 | 0,14% | Aktien |
| TEMA ETFS LLC | $2.000.422 | 75.975 | 0,13% | Aktien |
| RHUMBLINE ADVISERS | $1.962.211 | 75.066 | 0,13% | Aktien |
| Swiss National Bank | $1.939.588 | 74.200 | 0,13% | Aktien |
| MARTINGALE ASSET MANAGEMENT L P | $1.915.592 | 73.282 | 0,13% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.878.786 | 71.874 | 0,12% | Aktien |
| Dana Investment Advisors, Inc. | $1.873.192 | 71.660 | 0,12% | Aktien |
| CREDIT AGRICOLE S A | $1.855.940 | 71.000 | 0,12% | Aktien |
| Fisher Asset Management, LLC | $1.850.057 | 70.775 | 0,12% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $1.747.093 | 66.836 | 0,11% | Aktien |
| Verdad Advisers, LP | $1.743.224 | 66.688 | 0,11% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $1.705.583 | 65.248 | 0,11% | Aktien |
| Campbell & CO Investment Adviser LLC | $1.591.246 | 60.874 | 0,10% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.399.636 | 55.896 | 0,09% | Aktien |
| CITADEL ADVISORS LLC | $1.364.508 | 52.200 | 0,09% | Kaufoption |
| Virtus Investment Advisers, LLC | $1.328.566 | 50.825 | 0,09% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $1.272.365 | 48.675 | 0,08% | Aktien |
| Quantinno Capital Management LP | $1.245.362 | 47.642 | 0,08% | Aktien |
| WELLS FARGO & COMPANY/MN | $1.122.164 | 42.929 | 0,07% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $1.111.577 | 42.524 | 0,07% | Aktien |
| Bank of New York Mellon Corp | $1.076.785 | 41.193 | 0,07% | Aktien |
| MARSHALL WACE, LLP | $1.070.380 | 40.948 | 0,07% | Aktien |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1.033.419 | 39.534 | 0,07% | Aktien |
| Aquilo Capital Management, LLC | $1.006.181 | 84.482 | 0,07% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $965.141 | 36.922 | 0,06% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $953.352 | 36.471 | 0,06% | Aktien |
| HighTower Advisors, LLC | $943.654 | 36.100 | 0,06% | Aktien |
| Persistent Asset Partners Ltd | $939.341 | 35.935 | 0,06% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $936.221 | 37.389 | 0,06% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $904.653 | 34.608 | 0,06% | Aktien |
| HighVista Strategies LLC | $889.100 | 34.013 | 0,06% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $837.838 | 32.052 | 0,05% | Aktien |
| TWO SIGMA ADVISERS, LP | $827.157 | 31.415 | 0,05% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $807.360 | 30.886 | 0,05% | Aktien |
| SBI Okasan Asset Management Co.Ltd. | $771.200 | 32.000 | 0,05% | Aktien |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $735.529 | 27.935 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $728.888 | 27.884 | 0,05% | Aktien |
| JOURNEY STRATEGIC WEALTH LLC | $722.304 | 28.846 | 0,05% | Aktien |
| STRS OHIO | $692.710 | 26.500 | 0,05% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $686.933 | 26.279 | 0,04% | Aktien |
| Brevan Howard Capital Management LP | $678.490 | 25.956 | 0,04% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $657.735 | 25.162 | 0,04% | Aktien |
| RITHOLTZ WEALTH MANAGEMENT | $633.712 | 24.243 | 0,04% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $607.206 | 23.229 | 0,04% | Aktien |
| Duncan Williams Asset Management, LLC | $577.563 | 22.095 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $564.049 | 21.578 | 0,04% | Aktien |
| BARCLAYS PLC | $524.577 | 20.068 | 0,03% | Aktien |
| SIMPLEX TRADING, LLC | $507.926 | 19.431 | 0,03% | Aktien |
| Invesco Ltd. | $491.720 | 18.811 | 0,03% | Aktien |
Unternehmensinsider 28 Insider · 12 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kenneth Galbraith | Chair & CEO | 12. Januar 2026 A | 226.842 | 0 | 4 | $-3.337.929 |
| Kristin Stafford | EVP, Chief Financial Officer | 6. April 2026 A | — | 0 | 0 | $0 |
| Christopher Astle | SVP & Chief Financial Officer | 5. Januar 2024 A | 6.503 | 0 | 0 | $0 |
| Neil A Klompas | President & COO | 10. März 2023 M | 17.032 | 0 | 0 | $0 |
| Mark Hollywood | EVP & Chief Operating Officer | 6. Juli 2026 A | 133.852 | 0 | 1 | $-138.740 |
| Paul R Schneider | EVP, General Counsel | 13. Mai 2026 A | — | 0 | 0 | $0 |
| Adam Schayowitz | EVP, Head of Research & Development | 9. April 2026 A | — | 0 | 0 | $0 |
| Scott Platshon | EVP, Chief Business Officer | 9. April 2026 A | — | 0 | 0 | $0 |
| Paul Andrew Moore | Chief Scientific Officer | 12. Januar 2026 A | 48.497 | 0 | 3 | $-721.486 |
| Jeffrey T L Smith | EVP & Chief Medical Officer | 12. Januar 2026 M | 26.708 | 0 | 2 | $-475.562 |
| Leone D Patterson | EVP, Chief Bus & Fin Officer | 6. Januar 2026 A | 459 | 0 | 0 | $0 |
| Neil Josephson | Chief Medical Officer | 10. November 2022 M | 14.449 | 0 | 0 | $0 |
| Gregory A. Ciongoli | Direktor | 12. Januar 2026 A | 488.500 | 0 | 0 | $0 |
| Alessandra Cesano | Direktor | 12. Januar 2026 A | — | 0 | 0 | $0 |
| Carlos Campoy | Direktor | 12. Januar 2026 A | — | 0 | 0 | $0 |
| Robert E Landry | Direktor | 12. Januar 2026 A | — | 0 | 0 | $0 |
| Kelvin Neu | Direktor | 12. Januar 2026 A | — | 0 | 0 | $0 |
| Susan Mahony | Direktor | 12. Januar 2026 A | — | 0 | 0 | $0 |
| Brian N Cherry | Direktor | 12. Januar 2026 A | — | 0 | 0 | $0 |
| EcoR1 Capital, LLC | Direktor | 17. Januar 2025 P | 15.720.161 | 0 | 0 | $0 |
| Nancy Davidson | Direktor | 10. Dezember 2024 A | — | 0 | 0 | $0 |
| Neil Gallagher | Direktor | 10. Dezember 2024 A | — | 0 | 0 | $0 |
| Derek John Michael Miller | Direktor | 10. Dezember 2024 A | — | 0 | 0 | $0 |
| Troy Cox | Direktor | 10. Dezember 2024 A | — | 0 | 0 | $0 |
| Kenneth J. Hillan | Direktor | 7. Dezember 2023 A | — | 0 | 0 | $0 |
| Hollings Renton | Direktor | 7. Dezember 2023 A | — | 0 | 0 | $0 |
| Natalie Sacks | Direktor | 21. Dezember 2022 A | — | 0 | 0 | $0 |
| Lota S. Zoth | Direktor | 21. Dezember 2022 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC, Oleg Nodelman, EcoR1 Capital Fund Qualified, L.P. ×8 Einreichungen | 19. November 2025 | 30,70% | Änderung | Vorstandskampagne | SEC |
| All Blue Falcons FZE, Daniel Edward Llewellen Cookson ×2 Einreichungen | 28. Dezember 2022 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 41 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 1,51% | 105.615 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,80% | 10.832 NS | 30. April 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,49% | 186.247 NS | 30. April 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,25% | 110.902 NS | 30. April 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,15% | 16.669 NS | 31. Mai 2026 | N-PORT |
| SMMV · iShares Trust | 0,13% | 16.160 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,13% | 517.328 SH | 8. August 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,12% | 14.789 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,12% | 3.975 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 74.514 SH | 8. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 17.393 NS | 30. April 2026 | N-PORT |
| BIB · ProShares Trust | 0,09% | 2.766 NS | 31. Mai 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,07% | 50.443 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,07% | 423.822 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,06% | 67.771 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,04% | 21.639 NS | 30. April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 270.692 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,04% | 189.866 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.183.337 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,03% | 2.345 NS | 31. Mai 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 10.887 NS | 31. Mai 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 5.753 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,02% | 1.834 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 16.794 NS | 30. April 2026 | N-PORT |
| ISCB · iShares Trust | 0,02% | 1.999 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,01% | 5.891 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 1.855 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 3.008 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 110.298 SH | 8. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 5.236 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1.925 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 26.839 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 47 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5.213 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 72.902 NS | 30. April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 12.951 NS | 30. April 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 14.256 SH | 8. August 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 8.364 NS | 30. April 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 130 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.508.613 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.085 SH | 8. August 2026 | Täglich |